Results 91 to 100 of about 114,759,215 (188)

Novel A20-gene-eluting stent inhibits carotid artery restenosis in a porcine model

, 2016
Zhen-hua Zhou,1 Jing Peng,1 Zhao-you Meng,1 Lin Chen,1 Jia-Lu Huang,1 He-qing Huang,1 Li Li,2 Wen Zeng,2 Yong Wei,2 Chu-Hong Zhu,2 Kang-Ning Chen1 1Department of Neurology, Cerebrovascular Disease Research Institute, Southwest Hospital, 2Department of ...
Zhou ZH, Huang JL, Chen L, Meng ZY, Huang HQ, Li L, Zeng W, Wei Y, Zhu CH, Peng J, Chen KN   +10 more
core  

in-stent restenosis: restenosis on CCA after shortening of the carotid wall stent.

, 2016
A: CAROTID WALLSTENT 7–40 for a restenosis post CEA. B: shortening of the stent and early in-stent restenosis on CCA. The arrow is on the initial stent positioning.
Pierre-Edouard Magnan (3110859), Jean-Michel Bartoli (3110853), Philippe Piquet (2839199), Laurence Bal (3110850), Roch Giorgi (498963), Marine Gaudry (3110862), Mariangela De Masi (3110856)   +6 more
core   +1 more source

SGLT2i in heart failure: Cardiorenal mechanisms, clinical evidence and translational perspectives

Clinical and Translational Discovery, Volume 6, Issue 5, October 2026.
SGLT2 inhibitors improve heart failure outcomes through integrated cardiorenal mechanisms. In the kidney, they reduce glucose and sodium reabsorption, promoting natriuresis, osmotic diuresis and renal protection. In the heart, they enhance myocardial energetics, reduce inflammation, oxidative stress, fibrosis and adverse remodelling, resulting in fewer
Jelica Grujic‐Milanovic, Jovana Rajkovic, Radmila Novakovic, Javad Sharifi‐Rad, Daniela Calina   +4 more
wiley   +1 more source

Three-Year Outcomes, Risk Factors for Restenosis After Stenting for DVT Combined with Iliac Vein Compression Syndrome

Clinical and Applied Thrombosis/Hemostasis
This study aimed to evaluate the safety and efficacy of pharmacomechanical catheter-directed thrombolysis (PCDT) and stenting for treating acute iliofemoral deep venous thrombosis (DVT) combined with iliac vein compression syndrome (IVCS), and to ...
Lin Zhang MM, Chuli Jiang MD, Zheng Chen MD, Wei Song MD, Yu Zhao MD, PhD, Fenghe Li MD, PhD   +5 more
doaj   +1 more source

Diagnostic Performance of Complete Blood Count Derived Indices for Acute Coronary Syndrome in Emergency Department Patients With Acute Chest Pain: A Single‐Center Retrospective Diagnostic Accuracy Study

Health Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background and Aims Acute coronary syndrome (ACS), as one of the cardiovascular diseases, plays a significant role in patient mortality. Although appropriate diagnostic methods have been introduced for ACS, it still remains a challenge for physicians. Therefore, utilizing additional markers and ratios for the diagnosis of ACS can be beneficial.
Mohammad Ghorbani, Mostafa Shakeri, Elahe Rahimi, Ebrahim Salavati, Raheleh Derafshi, Mohamad Esmail Gheydari, Amirhossein Gholizadeh Behabadi   +6 more
wiley   +1 more source

Elevated BMI Is Not Associated With Adverse Outcomes in Open Airway Reconstruction

The Laryngoscope, Volume 136, Issue 10, Page 4219-4233, October 2026.
ABSTRACT Background Open airway reconstruction is indicated for structural airway stenoses but may be associated with significant morbidity. While obesity influences perioperative outcomes in many surgical domains, its role in airway reconstruction remains unclear.
Dylan Bertoni, Elizabeth Shuman, Choo Phei Wee, Karla O'Dell   +3 more
wiley   +1 more source

Recurrent intra-stent coronary restenosis in a carrier of non-disease-specific antinuclear antibodies

European Journal of Case Reports in Internal Medicine
Intracoronary in-stent restenosis (ISR) is a phenomenon that generally occurs between 3 and 6 months after stent placement. With the introduction of drug-eluting stents (DES), the incidence of ISR has decreased but not disappeared.
Benedetta Tomberli, Stefano Fumagalli, Tiziana Cristina Minopoli, Silvia Menale, Valentina Scheggi, Niccolò Marchionni   +5 more
doaj   +1 more source

Restenosis risk factors after coronary stenting in metabolic syndrome patients

Кардиоваскулярная терапия и профилактика, 2007
This review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus.
N. M. Danilov, T. T. Gorgadze, A. P. Savchenko, I. E. Chazova   +3 more
doaj  

Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis

Journal of the Pakistan Medical Association
Objective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan, Daniel Sukmadja, Kaka Citta Prasiddha, Rizkan Triatmaja   +3 more
doaj   +1 more source

Degraded products generated by iron stent inhibit the vascular smooth muscle cell proliferation by downregulating AP-1

Journal of Materials Science: Materials in Medicine
In-stent restenosis (ISR) following interventional therapy is a fatal clinical complication. Current evidence indicates that neointimal hyperplasia driven by uncontrolled proliferation of vascular smooth muscle cells (VSMC) is a major cause of restenosis.
Jiabing Huang, Bingjian Liu, Chunguang Zhao, Jing Li, Dongxu Qiu   +4 more
doaj   +1 more source